[
    [
        {
            "time": "2023-10-05",
            "original_text": "Pfizer Is the Dowâ€™s Worst Stock. A New Strategy Makes It Worth Another Look.",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Dow",
                    "Worst Stock",
                    "New Strategy"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Pharma Stock Roundup: FDA Nod to NVS & AZN's Drugs, BMY-CELG Merger Closes",
            "features": {
                "keywords": [
                    "FDA",
                    "NVS",
                    "AZN",
                    "Drugs",
                    "BMY-CELG",
                    "Merger"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: FDA Nod to NVS & AZN's Drugs, BMY-CELG Merger Closes",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]